CIP
IRMD icon

Cornerstone Investment Partners’s iRadimed IRMD Stock Holding History

Cornerstone Investment Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
2,842
-134
-5% -$12.2K 0.01% 209
2026
Q1 		$286K Buy
2,976
+673
+29% +$67.3K 0.01% 146
2025
Q4 		$224K Buy
+2,303
New +$198K 0.01% 151

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cornerstone Investment Partners's IRMD Position: Q2 2026 in Review

Cornerstone Investment Partners reduced its iRadimed (IRMD) stake by 4.5% in Q2 2026, selling an estimated $12.2K and leaving 2,842 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #209.

Cornerstone Investment Partners first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $286K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Cornerstone Investment Partners held 2,842 shares of iRadimed worth $272K as of Q2 2026.
  • Cornerstone Investment Partners sold 134 iRadimed shares in Q2 2026, an estimated $12.2K.
  • iRadimed made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #209 holding.
  • Cornerstone Investment Partners first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Investment Partners's iRadimed position peaked at $286K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.